$AKCA AKCEA THERAPEUTICS, INC. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AKCEA THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AKCEA THERAPEUTICS, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in AKCEA THERAPEUTICS, INC. for free.
IRS Number: 472608175
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: AKCA
Company Address: 22 BOSTON WHARF RD 9TH FLOOR BOSTON 02210
Phone number: 760-603-2732
AKCEA THERAPEUTICS, INC. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 14 2020 | AKCA | AKCEA THERAPEUTICS ... | IONIS PHARMACEUTICALS INC | 10% Owner | Buy | P | 18.15 | 21,237,715 | 385,464,527 | 98,322,397 | 77.1 M to 98.3 M (+27.55 %) |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | PRICE MICHAEL DENNIS | Chief Financial Off ... | Option Exercise | D | 14.78 | 300,000 | 4,434,000 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | PRICE MICHAEL DENNIS | Chief Financial Off ... | Sell | U | 18.15 | 50,000 | 907,500 | 0 | 50 K to 0 (-100.00 %) |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Patterson Joshua F. | General Counsel | Option Exercise | D | 12.76 | 7,500 | 95,700 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Patterson Joshua F. | General Counsel | Option Exercise | D | 16.99 | 13,750 | 233,613 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Patterson Joshua F. | General Counsel | Sell | U | 18.15 | 26,532 | 481,556 | 0 | 26.5 K to 0 (-100.00 %) |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Jenne Kyle | Chief Commercial Of ... | Option Exercise | D | 12.76 | 34,200 | 436,392 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Jenne Kyle | Chief Commercial Of ... | Option Exercise | D | 17.38 | 13,701 | 238,123 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Jenne Kyle | Chief Commercial Of ... | Option Exercise | D | 17.38 | 299 | 5,197 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Jenne Kyle | Chief Commercial Of ... | Option Exercise | D | 12.21 | 32,751 | 399,890 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Jenne Kyle | Chief Commercial Of ... | Option Exercise | D | 12.21 | 143,374 | 1,750,597 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Jenne Kyle | Chief Commercial Of ... | Sell | U | 18.15 | 52,012 | 944,018 | 0 | 52 K to 0 (-100.00 %) |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Howarth Alex G. | Chief Operating Off ... | Option Exercise | D | 12.76 | 34,200 | 436,392 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Howarth Alex G. | Chief Operating Off ... | Option Exercise | D | 17.94 | 300,000 | 5,382,000 | 0 | |
| Oct 13 2020 | AKCA | AKCEA THERAPEUTICS ... | Howarth Alex G. | Chief Operating Off ... | Sell | U | 18.15 | 66,800 | 1,212,420 | 0 | 66.8 K to 0 (-100.00 %) |